Please assess the completion status of the following clinical trial:

Trial Title: Treating Refractory Schizophrenia With rTMS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients enrolling to the study:~  * must be stable on their medications at the start of their enrollment in the study and throughout the duration of the study;~ * must have no history of substance use of substance-dependence issues over at least the past six months;~ * must be able to and have the capacity to provide consent;~ * and if older patient, he/she must be able to participate without a safeguard to be present.~Exclusion Criteria:~* Patients excluded from the study are:~  * Patients with typical clinical considerations that exclude them from treatment with TMS (i.e., patients who have had head injuries, patients with metal implants, patients with a history of seizures, patients with elevated risk of seizures, patients who are taking medications that may interfere with TMS or potentiate the related side effects, etc.).~ * Patients who have had changes in their medications (i.e., patients must be stable on their medications throughout their participation in the study).~ * Patients with history of substance abuse or substance-dependence anytime over the past six months.~ * Patients who are unable (i.e., do not have the capacity) to consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Active (Type: EXPERIMENTAL): Active rTMS stimulation (1 Hz rTMS, 10 Hz rTMS)
- Placebo (Type: EXPERIMENTAL): Sham rTMS stimulation (1 Hz rTMS, 10 Hz rTMS)

Based on this trial design, predict the completion outcome and termination type (if applicable).